Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Completed · Not applicable

Conditions studied: Head and Neck Cancer Survivors, Cancer of the Head and Neck Surviors

In brief

To evaluate the effectiveness, feasibility, acceptability, and appropriateness of an ototoxicity screening protocol among head and neck (H\&N) cancer patients followed in survivorship clinic that received cisplatin-based chemoradiation therapy (CRT).

Key facts

Study ID

NCT05789316

Run by

Washington University School of Medicine

People needed

55

Starts

2023-06-06

Expected to finish

2025-11-21

Last updated by the study team

2026-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (≥ 18 years old)
• H\&N cancer patients will be eligible for inclusion if they have previously undergone cisplatin-based CRT or radiotherapy, including proton therapy, intensity-modulated radiation therapy, and adaptive radiotherapy-surgery with curative intent (i.e., definitive, neoadjuvant, or adjuvant) or definitive surgery with neoadjuvant or adjuvant radiation.

You may not qualify if…

• Patient has been evaluated by an audiologist within the past 12 months
• Use of a hearing aid
• Received a cochlear implant
• Cannot complete simple forms in English

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.